Lenalidomide (CC5013, Revlimid®) Promotes T Helper-1 Function Bias and Increases Responsiveness to Autologous Bone Marrow Antigens in Myelodysplastic Syndrome (MDS).
| Autor: | Ku, Edna, Zou, JianXiang *, Bai, Fanqi *, Painter, Jeffrey S. *, List, Alan F., Epling-Burnette, P.K. |
|---|---|
| Zdroj: | In Blood 16 November 2006 108(11):2659-2659 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|